Cargando…

Impact of delisting OTC medicines from reimbursement list

Detalles Bibliográficos
Autores principales:	Chytilová, Petra, Šebesta, Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603739/ http://dx.doi.org/10.1186/2052-3211-8-S1-P4

Ejemplares similares

Biennial Report on Carcinogens Listing/Delisting Procedure
Publicado: (1996)

The listed, delisted, and sustainability of therapeutic medicines for dementia patients: the study is specific to South Korea
por: Lee, Jong Hoon
Publicado: (2022)

Retrospective financial analysis of medicines reimbursement services in community pharmacy
por: Chitan, Elena
Publicado: (2015)

Reimbursement categories as a way of allocating measures and monitoring expenditures on medicines
por: Lipińska, Aneta, et al.
Publicado: (2015)

Frequent Follow-Up of Delisted Liver Transplant Candidates Is Necessary: An Observational Study about Characteristics and Outcomes of Delisted Liver Transplant Candidates
por: Payani, Elnaz, et al.
Publicado: (2023)

A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate
por: Docteur, Elizabeth, et al.
Publicado: (2015)

Diagnosis-related group-based reimbursement is unrealistic for ICUs
por: Mclaughlin, A, et al.
Publicado: (2009)

The impact of Ghana's National Health Insurance Scheme median pharmaceutical pricing methodology and reimbursement policy on the pharmaceutical system
por: Mordi, Dumebi O, et al.
Publicado: (2015)

Reimbursement measures in European countries – findings of a bibliometric literature review
por: Vogler, Sabine, et al.
Publicado: (2015)

Quantifying the effects of delisting wolves after the first state began lethal management
por: Treves, Adrian, et al.
Publicado: (2021)

Consumer Impressions of the Safety and Effectiveness of OTC Medicines
por: Taylor, Jeffrey Gordon, et al.
Publicado: (2023)

Consumer Likelihood to Seek Information on OTC Medicines
por: Taylor, Jeffrey G., et al.
Publicado: (2023)

Critical Appraisal of Reimbursement List in Bosnia and Herzegovina
por: Mujkic, Sabina, et al.
Publicado: (2017)

Defining the Relationship Between Firm’s Performance and Delisting: Empirical Evidence of Going Private in Europe
por: Magni, Domitilla, et al.
Publicado: (2021)

Cutting costs – the impact of price-lists on the cost development in the emergency department
por: Schilling, Ulf Martin
Publicado: (2009)

Approval, reimbursement and pricing of high-cost cancer medicines in Australia
por: Vitry, Agnes
Publicado: (2015)

Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada
por: Martins, Diana, et al.
Publicado: (2019)

Evidence for the effectiveness of anti-hypertensive medicines included on the Chinese National Reimbursement Drug List
por: Liu, Wenbin, et al.
Publicado: (2019)

Using the WHO Essential Medicines List to Assess the Appropriateness of Insurance Coverage Decisions: A Case Study of the Croatian National Medicine Reimbursement List
por: Jeličić Kadić, Antonia, et al.
Publicado: (2014)

Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment
por: Kazakov, Rossen M, et al.
Publicado: (2015)

Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil
por: Santa-Ana-Tellez, Yared, et al.
Publicado: (2015)

Impact of DRG reimbursement system on hospital efficiency: systematic review
por: Tabrizi, Hossein Moshiri
Publicado: (2012)

The duration of cost-cutting effects of price-lists
por: Schilling, Ulf Martin
Publicado: (2010)

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
por: Macabeo, Bérengère, et al.
Publicado: (2023)

Differences in reimbursement listing of anticancer therapies in China: an observational study
por: Guan, Xiaodong, et al.
Publicado: (2020)

The Medical Unit of the O.T.C.
Publicado: (1910)

Cardiorenal Safety of OTC Analgesics
por: White, William B., et al.
Publicado: (2018)

Bréve: Chloroquine OTC : danger !
por: Dalmat, Yann-Mickael
Publicado: (2020)

Bréve : Chloroquine OTC : danger !
por: Dalmat, Yann-Mickael
Publicado: (2020)

The Impact of the Socio-Demographic Characteristics of Complementary and Alternative Medicine Users in Serbia on OTC Drug Consumption
por: Luketina-Sunjka, Marina, et al.
Publicado: (2019)

Where to buy OTC medications? A cross-sectional survey investigating consumers’ confidence in over-the-counter (OTC) skills and their attitudes towards the availability of OTC painkillers
por: Brabers, A E M, et al.
Publicado: (2013)

Wolf Delisting Challenges Demonstrate Need for an Improved Framework for Conserving Intraspecific Variation under the Endangered Species Act.
por: Carroll, Carlos, et al.
Publicado: (2020)

Consensus on the need for a hierarchical list of patient-reported pain outcomes for meta-analyses of knee osteoarthritis trials
por: Klokker, Louise, et al.
Publicado: (2015)

Stratified Medicine and Reimbursement Issues
por: Fugel, Hans-Joerg, et al.
Publicado: (2012)

Use of OTC-drugs prior to Hospitalization
por: Pedersen, Magnus, et al.
Publicado: (2013)

Marketing approaches for OTC analgesics in Bulgaria
por: Petkova, Valentina, et al.
Publicado: (2014)

Molecular adsorbent recirculating system treatment in 69 patients listed for liver transplantation
por: Olin, P, et al.
Publicado: (2015)

The acceptance of price lists at the emergency department: how do doctors think about it?
por: Schilling, Ulf Martin
Publicado: (2010)

What is the Role of Over 100 Excipients in Over the Counter (OTC) Cough Medicines?
por: Eccles, Ronald
Publicado: (2020)

Budget Impact of Introducing Linagliptin into Bosnia and Herzegovina Health Insurance Drug Reimbursement List in 2016-2018
por: Catic, Tarik, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qg2to1mfoobsn7587eocavmd6n